Evaluation of a new third-generation ELISA for the detection of HIV infection

Annals of Clinical and Laboratory Science

Volumn 36, Issue 1, 2006, Pages 73-78

  Yeom, Joon Sup ^a   Lee, Jae Beom ^b   Ryu, Seung Ho ^a   Kang, Hee Jung ^c   Kim, Sunhil ^b   Kim, Young A ^b   Ahn, Sun Young ^b   Cha, Je Eun ^b   Park, Jae Won ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

Author keywords

ELISA; HIV antibody detection; HIV 1; HIV 1 group O; HIV 2

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEROTYPE;

AIDS SERODIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33744468277     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Thorstensson R, Andersson S, Lindbaeck S, Dias F, Mhalu F, Gaines H, Biberfeld G. Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Virol Meth 1998;70:139-151.
2. Brust S, Duttmann H, Feldner J, Gurtler L, Rigmor T, Simon F. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. J Virol Meth 2000;90:153-165.
3. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Courouce AM, Brun-Vezinet F, Simon F. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-1394.
4. van Binsbergen J, de Rijk D, Peel H, Dries C, Scherders J, Koolen M, Zekeng L, Gurtler LG. Evaluation of a new third generation anti-HIV-1/anti-HIV-2 assay with increased sensitivity for HIV-1 group O. J Virol Meth 1996;60:131-137.
5. van Binsbergen J, Keur W, van de Graaf M, Siebelink A, Jacobs A, de Rijk D, Toonen J, Zekeng L, Afane Ze E, Gurtler L. Reactivity of a new HIV-1 group O third generation a-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O/group M subtyped samples. J Virol Meth 1997;69:29-37.
6. Apetrei C, Loussert-Ajaka I, Descamps D, Damond F, Saragosti S, Brun-Vezinet F, Simon F. Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS 1996;10:F57-F60.
7. Christiansen CB, Jessen TE, Nielsen C, Staun-Olsen P. False negative anti-HIV-1/HIV-2 ELISAs in acute HIV-2 infection. Vox Sang 1996;70:144-147.